EVEROLIMUS BIOGARAN 2,5 mg, comprimé — plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930152676 -
CIP7
3015267 -
CIS
63445939
What the source publishes
- Holder
- BIOGARAN
- Active ingredients
- ÉVÉROLIMUS
- Form
- comprimé
- Package
- plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2018-07-03
- Prescription
- Prescription or restricted
Names this record is found by
- EVEROLIMUS BIOGARAN 2,5 mg, comprimé — plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- EVEROLIMUS BIOGARAN 2,5 mg, comprimé
- ÉVÉROLIMUS
Complete source data
{
"cis": "63445939",
"cip7": "3015267",
"form": "comprimé",
"name": "EVEROLIMUS BIOGARAN 2,5 mg, comprimé — plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)",
"cip13": "3400930152676",
"holder": "BIOGARAN",
"routes": [
"orale"
],
"holders": [
"BIOGARAN"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "457.00",
"authorisedOn": "2018-07-03",
"compositions": [
{
"name": "ÉVÉROLIMUS",
"nature": "SA",
"strength": "2,50 mg",
"linkageNumber": "1",
"substanceCode": "94553",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "455.98",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "EVEROLIMUS BIOGARAN 2,5 mg, comprimé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2019-10-07",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ÉVÉROLIMUS"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930152676"